Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05831241 · ClinicalTrials.gov registry record · NA
Effects of Ashwagandha Extract (Capsule KSM-66 300 mg) on Sexual Health in Healthy Women
A NA study, sponsored by SF Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05831241 is a NA study that has completed, run by SF Research Institute. The registered enrollment target is 45 participants.
The verdict
NCT05831241, a NA study, has completed, sponsored by SF Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The clinical study aims to evaluate Efficacy and Safety of KSM66 Ashwagandha Standardized Root Extract for Improving Sexual Health in Healthy Women by measuring the sex hormone levels in blood, analyzing results of questionnaires, and monitoring adverse events in the post-marketing phase. Changes in sex hormone levels in blood may affect sexual health or sexual health satisfaction. Efficacy is defined as increase in sex hormone levels in blood, and improvements in results or scores in assessment questionnaires.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Ashwagandha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-07-12 |
| Est. Completion | 2024-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05831241
The ClinicalTrials.gov registry entry for NCT05831241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SF Research Institute, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05831241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05831241 about?
NCT05831241 is a clinical study titled "Effects of Ashwagandha Extract (Capsule KSM-66 300 mg) on Sexual Health in Healthy Women". The clinical study aims to evaluate Efficacy and Safety of KSM66 Ashwagandha Standardized Root Extract for Improving Sexual Health in Healthy Women by measuring the sex hormone levels in blood, analyzing results of questionnaires, and monitoring adverse events in the post-marketing phase. Changes in...
What is the current status of trial NCT05831241?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2023-07-12. Estimated completion is 2024-12-20.
What interventions are being tested in trial NCT05831241?
The interventions under investigation include: Placebo (OTHER), Ashwagandha (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05831241?
This trial is sponsored by SF Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.